CIK 0001603454 · Non-accelerated filer<br>Smaller reporting company
Celcuity Inc.
Sign in to watch- Ticker
- CELC
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 763-392-0767
- Business address
- 16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
- Former names
- Celcuity LLC
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale Director sold 750 shares at $6.24 ($4,683)
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 250 shares at $5.65 ($1,413)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 3,273 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Other events
- SC 13G Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market sale Director sold 300 shares at $7.34 ($2,202)
- DEF 14A Proxy Proxy Statement
Page 17 of 28 · 542 filings